Literature DB >> 29697193

Solid pseudopapillary and malignant pancreatic tumors in childhood: A systematic review and evidence quality assessment.

Konstantinos S Mylonas1,2, Ilias P Doulamis3, Diamantis I Tsilimigras3,4, Dimitrios Nasioudis3,5, Dimitrios Schizas3,4, Peter T Masiakos1, Cassandra M Kelleher1.   

Abstract

A systematic review of 32 studies reporting on 489 children with pancreatic tumors was performed. The most prevalent histologic subtype was solid pseudopapillary tumor (SPT) (61.3%). Pancreaticoduodenectomy was the most commonly performed operation (48%). Neoadjuvant chemo/radiotherapy was utilized in 3.9, 36.2, 25, and 27.8% of patients with SPTs, pancreatoblastomas (PBLs), neuroendocrine tumors, and exocrine carcinomas, respectively. Adjuvant chemotherapy (75.6%) and radiation (34%) were most commonly utilized in PBLs. All-cause mortality was highest in exocrine carcinomas (50%). Overall, 98.8% of patients with SPTs survived. PBL exhibited the highest recurrence rate (14.7%) within a mean of 23.5 months.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  pancreatic neuroendocrine tumors; pancreatic tumors; pancreatoblastoma; pediatric; solid pseudopapillary tumors

Mesh:

Year:  2018        PMID: 29697193     DOI: 10.1002/pbc.27114

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  2 in total

1.  Early postoperative complications in pediatric abdominal solid tumor surgery according to Clavian-Dindo classification.

Authors:  İdil Rana User; Burak Ardıçlı; Arbay Özden Çiftçi; İbrahim Karnak; Feridun Cahit Tanyel; Berna Oğuz; Mithat Haliloğlu; Tezer Kutluk; Ali Varan; Saniye Ekinci
Journal:  Pediatr Surg Int       Date:  2022-07-12       Impact factor: 2.003

2.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.